TITLE

THE NEW PRESCRIPTIONS

PUB. DATE
October 2012
SOURCE
Marie Claire (US Edition);Oct2012, Vol. 19 Issue 10, p270
SOURCE TYPE
Periodical
DOC. TYPE
Product Review
ABSTRACT
The article offers a preview on the two diet medications approved by the U.S. Food and Drug Administration (FDA), the Belviq and the combined phentermine and topiramate drug called Qsymia and another drug, the Contrave, which is to be reviewed by the agency after it was rejected in 2011.
ACCESSION #
86283130

 

Related Articles

  • GPs should join debate on potential risk versus reward of obesity drug. Castaneda, Reynald // New Zealand Doctor;10/8/2014, p14 

    The article focuses on the debate by general practitioners (GP) and clinicians in New Zealand on the risks and reward of the obesity drug phentermine.

  • FDA Warning on Chinese Diet Pills Containing Fenfluramine.  // FDA Consumer;Sep/Oct2002, Vol. 36 Issue 5, p7 

    Reports on warnings about Chinese weight-loss products from the U.S. Food and Drug Administration. Risks from Chaso Diet Capsules and Chaso Genpi; Deaths in Japan; Danger of the toxic ingredient, aristolochic acid; Lethal combination of fenfluramine and phentermine.

  • Combination phentermine and topiramate effective obesity therapy.  // Australian Journal of Pharmacy;Oct2011, Vol. 92 Issue 1097, p81 

    The article presents information on an effective treatment of obesity by the controlled-release combination of drugs phentermine and topiramate. As stated, this combination of drugs is expected to be known by a proposed name Qnexa which is not approved by the U.S. Food and Drug Administration...

  • Lorcaserin: A novel antiobesity drug. Brashier, Dick B. S.; Sharma, A. K.; Navdeep Dahiya; Singh, S. K.; Anjan Khadka // Journal of Pharmacology & Pharmacotherapeutics;Apr-Jun2014, Vol. 5 Issue 2, p175 

    Obesity is a major co-morbidity with hypertension and diabetes mellitus. There are few drugs for treatment of obesity like orlistat and recentlty approved drug lorcaserin. Lorcaserin has serotonergic properties and acts as an anorectic. It may cause serious side effects, including serotonin...

  • ANOREXIGENIC DRUGS IN THE TREATMENT OF OBESITY: PAST, PRESENT AND FUTURE. ┼×tefania, Todea; Gabriel, Hancu // Acta Medica Marisiensis;2019 Supplement, Vol. 65, p69 

    Background: Obesity is a medical condition in which the subject carries an excess weight; and represents a great problem in modern society. Obesity is related to multiple reasons, including diet, lifestyle, pathological conditions, genetic factors or the use of certain medications. It can...

  • Specific Medications for Weight Loss. Jin, Jill // JAMA: Journal of the American Medical Association;8/18/2015, Vol. 314 Issue 7, p742 

    The article assesses medications for weight loss. Medications addressed include orlistat, lorcaserin, and the combination of phentermine and topiramate. Also addressed are the combination of bupropion and naltrexone and the medication liraglutide. Other topics include the risks of stimulant...

  • Pulmonary Hypertension Associated with Use of Phentermine. Woo-Dae Bang; Ji-Ye Kim; Hee-Tae Yu; Sung-Soo Cho; Ji-Yong Jang; Chang-Myung Oh; Boyoung Joung; Hyuk-Jae Chang // Yonsei Medical Journal;11/1/2010, Vol. 51 Issue 6, p971 

    Weight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of breath and was diagnosed with pulmonary hypertension. Three months ago, she had been taking...

  • OBESITY DRUGS Not a Quick Fix.  // USA Today Magazine;Oct2000, Vol. 129 Issue 2665, p6 

    Provides information on the use of diet pills to reduce the weight of obese patients. Complications and side effects of diet pills; Benefits of diet and exercise therapy; Observation on the lifestyle of obese patients.

  • Current Concepts in the Pharmacological Management of Obesity. Carek, P.J.; Dickerson, L.M. // Drugs;Jun1999, Vol. 57 Issue 6, p883 

    The pharmacological management of obesity has gained increasing attention as new weight loss treatments are approved and a significant proportion of the public strives to lose weight. Obesity is associated with a high mortality rate, multiple chronic medical conditions, and carries an enormous...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics